Roche and Incyte dive into companion Dx work; Judge denies Illumina's bid to overturn patent case payment order;

> Roche's ($RHHBY) Ventana Medical Systems will work with Incyte ($INCY) to develop companion diagnostics for its oncology drug programs. Item

> A federal court denied Illumina's ($ILMN) motion to overturn an order that it fork over $115.1 million to Syntrix Biosystems in a patent-infringement lawsuit. Story (reg. req)

> Exagen Diagnostics nailed down a loan for up to $25 million that will help the New Mexico company expand sales efforts for its rheumatology tests. Item

> A blood test designed to spot changes in the TFP12 gene is being eyed as a way to diagnose melanoma metastasis. Story

> Researchers are optimistic about a new blood test that could help spot a woman's risk of preeclampsia during pregnancy. Story

> Seventh Sense Biosystems in Cambridge, MA, won a CE mark for its touch-activated phlebotomy technology for blood collection and diagnostic testing. Item

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.